Glucagon effects on ischemic vasodilatation in the isolated rat heart

dc.contributor.authorRosic, Mirko
dc.contributor.authorPantović J.
dc.contributor.authorRosic, Gvozden
dc.contributor.authorTomic Lucic, Aleksandra
dc.contributor.authorLabudovic T.
dc.contributor.authorZivkovic V.
dc.contributor.authorJakovljevic V.
dc.date.accessioned2021-04-20T15:12:26Z
dc.date.available2021-04-20T15:12:26Z
dc.date.issued2010
dc.description.abstractThe myocardial reperfusion following ischemia leads to the ischemic vasodilation by affecting the release of various vasoactive substances, such as free radicals, NO, and histamine. In addition, some evidences suggest that glucagon itself may alter the release of those substances. In this study, we investigated the ischemic vasodilation of the isolated rat heart, as well as the concentrations of NO, TBARS, and histamine in the coronary venous effluent either in the presence or in the absence of glucagon. Our results showed that in the presence of glucagon, there was a faster restoration of coronary perfusion pressure during ischemic vasodilation compared to the absence of glucagon (124 ± 5.6 versus 81 ± 5.2 s) with no apparent changes in TBARS concentration. The glucagon's administration leads to the decreased release of histamine by approximately 35%. Biphasic release of NO in the presence of glucagon initially showed augmentation by 60, followed by the significant attenuation of 45%. © 2010 Mirko Rosic et al.
dc.identifier.doi10.1155/2010/231832
dc.identifier.issn1110-7243
dc.identifier.scopus2-s2.0-77951686399
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/10229
dc.rightsopenAccess
dc.rights.licenseBY-NC-ND
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceJournal of Biomedicine and Biotechnology
dc.titleGlucagon effects on ischemic vasodilatation in the isolated rat heart
dc.typearticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.1155-2010-231832.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format